Compounding Advocacy Group Has New Name, Website
Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding.
Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding (APC). As of January 1, 2020, the new name has become official.
The name change follows a relocation of the organization’s headquarters from Houston, Texas to Alexandria, Virginia, in July 2019.
The organization’s new logo and
“We'll be welcoming these new constituencies to our organization because there's strength in numbers,” Burch said, in a prepared statement. “Pharmacy compounding professionals, prescribers, and patients alike stand to gain from our advocacy work."
The APC is an advocate on a number of issues related to patient access to compounded medications, including: encouraging national academies and chapters to seek input from prescribers, and dispensers of compounded bioidentical hormone replacement therapy; appealing beyond-use date restrictions in the new USP <795> and <797> chapters; and proposing a “middle way” to the FDA on a memorandum of understanding regarding state level regulation of patient-specific compounded medications.
Looking ahead in 2020, the APC plans to accomplish different strategies towards their success, such as:
- Assuring patient access to compounded medications
- Ensuring that compounding professionals have the knowledge and resources needed to excel in pharmacy compounding
- Building a multi-disciplinary community of compounding pharmacy professionals engaged in learning from each other
REFERENCE
Compounding group becomes Alliance for Pharmacy Compounding [news release]. Alexandria, VA: A4PC; January 7, 2020. [email]. Accessed January 7, 2020.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025